about
Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primatesSize- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates.Neutrophil Responses to Sterile Implant MaterialsCore-shell hydrogel microcapsules for improved islets encapsulation.Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy.Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent miceModular 'click-in-emulsion' bone-targeted nanogels.Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenograftsConditionally replicating adenoviruses for cancer treatment.Corrigendum: Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates.Human telomerase reverse transcriptase promoter-driven oncolytic adenovirus with E1B-19 kDa and E1B-55 kDa gene deletionsIntermittent metronomic drug schedule is essential for activating antitumor innate immunity and tumor xenograft regression.VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity-induced tumor regression.Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT.Colony stimulating factor-1 receptor is a central component of the foreign body response to biomaterial implants in rodents and non-human primatesAnti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2A Facile and Versatile Method to Endow Biomaterial Devices with Zwitterionic Surface Coatings.Endothelial siRNA delivery in nonhuman primates using ionizable low-molecular weight polymeric nanoparticles.Corrigendum: Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent miceDelivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activationLong-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations
P50
Q27313644-A4BA62BA-49EF-445F-92D5-3E7FB1A75CDFQ27314755-F318B438-0433-4140-BE1E-2338DE0CF9D7Q27318618-2B1098C0-91B5-4860-BFBD-73C9D2F47B30Q30439009-1241324F-E73D-4BE4-9D23-B17889E68AF1Q33754817-8B20637B-C94C-4993-BAB4-54548799874CQ34045963-7EF7F64D-A4C4-4CE4-9AAF-DA1F76BD88E3Q34320432-C54DE7E4-61FC-4CC3-846B-6D67CC82B72CQ35624661-D6356F39-ADB2-4D63-A26F-559726CC3F51Q35967313-FEA901C4-F287-4ED2-84AA-E9DFEBD3F4E7Q36047095-E86CF5FD-F896-4E62-BF62-9B6898078D10Q37274247-91DF2EDD-9DF2-4E15-92D7-E74A992F7B5AQ37584300-326DE56A-4879-45B5-8E34-F32473A2CC9DQ39413633-21B43091-CF67-4B60-976B-845986F2A8A5Q39652106-828EEBC7-D87E-4748-8E51-8983A528B51FQ41716521-1D2C9C69-482F-4B21-86EB-851C6B6D91ECQ42037461-33050174-43A4-4984-A361-A7EF9114DB1CQ51079293-46E4E439-D373-4686-BD7D-2B5B8FC1899BQ55513382-55C0B06E-3077-4498-A2B0-EF6A5C723FA1Q89131757-BD155032-5045-408B-85C9-33954B3B8B1DQ90391422-D4319B36-FE81-4197-AC6A-B4D7630D238AQ93001062-80F8D276-49FF-425B-B1C4-6AD750B52413
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joshua C Doloff
@nl
Joshua C Doloff
@sl
Joshua C. Doloff
@en
Joshua C. Doloff
@es
type
label
Joshua C Doloff
@nl
Joshua C Doloff
@sl
Joshua C. Doloff
@en
Joshua C. Doloff
@es
prefLabel
Joshua C Doloff
@nl
Joshua C Doloff
@sl
Joshua C. Doloff
@en
Joshua C. Doloff
@es
P106
P1153
16300587700
P31
P496
0000-0002-4323-3264